Page 30 - SAMRC Annual Performance Plan 2026-27
P. 30

PART B: SAMRC STRATEGIC FOCUS
            continued








            requires flexibility and fluidity that allows for thinking   that South Africa is hosting for the World Health
            across, beyond and through disciplines, but also   Organisation as well as the South African vaccine
            requires great depth and rigour in the attendant   manufacturing strategy, led by the DSI. The DSI is
            disciplines. Research also contributes to developing   the recipient of the KfW financial support on behalf
            intellectually engaged citizens who can participate   of the South African government and the SAMRC
            meaningfully  in  their  political,  social  and  cultural   is the project executing agency. The programme
                 3
            lives” .                                           will provide critical support to bolstering vaccine
                                                               research and development, including pre-clinical
            9.2.6  Localization of Research and                research, infrastructure and  establishing  a vaccine
                    Development and Innovation                 manufacturing industry in South Africa.
            The SAMRC facilitated a study to better understand
            the size, characteristics and dynamics of the medical   Localisation of research and development (R&D)
            devices industry, to acquire more information on   has profound impact on fostering innovation at
            local capabilities, expertise and stakeholders within   scale. Localising R&D efforts can cultivate innovative
            the value chain, such as for product development,   solutions that directly address the health challenges
            testing, manufacture, market introduction and      confronting South Africans. This commitment entails
            commercialisation, and to identify any gaps and    investing in local talent, forging partnerships with
            barriers.                                          domestic institutions, and conducting research
                                                               aligned with the South African context. The 2 nd
            This medical device landscaping survey has added   Presidential Health Compact 2024-2029 mandates
            to the existing understanding of the medical       the academic institutions, the South African Medical
            device innovation and manufacturing ecosystem      Research Council, and the Council for Scientific and
            in South Africa. It has revealed important aspects   Industrial Research to collaborate and produce a
            regarding the size and shape of the manufacturing   joint strategy to fast-track research and development
            sector, the country’s knowledge generating capacity   processes, mainly focusing on the co-development
            manifested in its STI institutions and the support   of state-owned intellectual property.
            infrastructure available to manufacturing companies
            and  STI  institutions.  Importantly,  it  has  reaffirmed   9.2.7  Artificial Intelligence
            and added to the previous knowledge base around    Emerging technologies, such as Artificial Intelligence
            the key gaps and barriers that have been hampering   (AI), machine learning, and quantum computing, are
            the growth of the sector.                          transforming the world at an unprecedented pace.
                                                               These powerful tools have the potential to solve
            In September 2023, the Department of Science       some of the greatest global health and development
            and Innovation (DSI) announced the conclusion      challenges,  from infectious diseases  to climate
            of  a  financing  agreement  with  Germany's  KfW   change  to poverty and  inequality  –  if developed
            Development Bank to produce vaccines. Under        responsibly, safely, and ethically. According to
            the agreement the German government, through       the WHO Global Strategy on Digital Health,
            KfW,  will  provide  South  Africa  with  €20  million  for   technologies are rapidly transforming healthcare
            vaccine development and production infrastructure   delivery worldwide, streamlining patient information
            over a period of five years. The grant is exclusively   management, enabling remote consultations, and
            for  financing  equipment  for  the  development,   empowering individuals to monitor their health.
            production and certification of active pharmaceutical   However, these innovations must be developed by
            ingredients for vaccine production in South Africa.   and for communities where global health challenges
            The grant will be used, among other things, to     are most acute, particularly in LMICs, for the greatest
            support the mRNA Technology Transfer Hub           impact.





            3  STI Decadal Plan - 14Dec23 (Approved).pdf. Accessed 2 September 2024


            28                      SAMRC ANNUAL PERFORMANCE PLAN 2026/27
   25   26   27   28   29   30   31   32   33   34   35